Atlas Trials

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Clinical trial NCT00089401 · COMPLETED

Trial details

NCT number
NCT00089401
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CancerMetastatic Cancer
Start date
2004-07-01
Primary completion
2006-11-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.